NCT04167137 2024-05-03Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult ParticipantsSynlogicPhase 1 Terminated32 enrolled 19 charts
NCT03465891 2021-01-12Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular LymphomaMemorial Sloan Kettering Cancer CenterPhase 2 Terminated2 enrolled 6 charts